Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular clodronate dose-finding in painful knee osteoarthritis
2024-511961-12-00Phase 3Authorised
- Sponsor
- Società Prodotti Antibiotici
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clodronate in knee osteoarthritis (OA) (4 arms), sponsored by Società Prodotti Antibiotici. Primary endpoint: Primary efficacy endpoint. Planned start Aug 2024; status: authorised.
02
Drugs
clodronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-511961-12-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511961-12-00.